Key Laboratory of Inflammation and Immunoregulation, School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing City 210046, China.
Acupuncture and Tuina College, Nanjing University of Chinese Medicine, Nanjing City 210023, China.
Theranostics. 2022 Mar 21;12(6):2928-2947. doi: 10.7150/thno.69533. eCollection 2022.
Aberrant activation of macrophages with mitochondria dismiss was proved to be associated with pathogenesis of ALI (acute lung injury). Exosomes from adipose-derived mesenchymal stem cells (AdMSC-Exos) have been distinguished by their low immunogenicity, lack of tumorigenicity, and high clinical safety, but their role in treating ALI and the mechanism involved need to be defined. In this study, we sought to investigate whether the mitochondrial donation from AdMSC-Exos provides profound protection against LPS-induced ALI in mice, accompanied by improvement of macrophage mitochondrial function. C57BL/6 mice were orotracheally instilled with LPS (1 mg/kg). AdMSC-Exos were administered via the tail vein 4 h after LPS inhalation. Flow cytometry, H&E, Quantitative Real-Time PCR, immunofluorescence (IF), confocal microscopy imaging was conducted to investigate lung tissue inflammation and macrophage mitochondrial function. And further observe the transfer of exosomes and the effect on mitochondrial function of MH-S cells through experiments. AdMSC-Exos can transfer the stem cell-derived mitochondria components to alveolar macrophages in a dose-dependent manner. Likely through complementing the damaged mitochondria, AdMSC-Exos exhibited the ability to elevate the level of mtDNA, mitochondrial membrane potential (MMP), OXPHOS activity and ATP generation, while reliving mROS stress in LPS-challenged macrophages. Restoring mitochondrial integrity via AdMSC-Exos treatment enabled macrophages shifting to anti-inflammatory phenotype, as featured with the down-regulation of IL-1β, TNF-α and iNOS secretion and increase in production of anti-inflammatory cytokines IL-10 and Arg-1. As we depleted alveolar macrophages using clodronate liposomes, the protective role for AdMSC-Exos was largely abrogated. AdMSC-Exos can effectively donate mitochondria component improved macrophages mitochondrial integrity and oxidative phosphorylation level, leading to the resumption of metabolic and immune homeostasis of airway macrophages and mitigating lung inflammatory pathology.
异常激活的巨噬细胞伴有线粒体耗竭被证明与 ALI(急性肺损伤)的发病机制有关。脂肪间充质干细胞(AdMSC-Exos)来源的外泌体因其低免疫原性、无致瘤性和高临床安全性而备受关注,但它们在治疗 ALI 中的作用及其涉及的机制仍需进一步明确。在这项研究中,我们试图探讨 AdMSC-Exos 的线粒体供体是否能为 LPS 诱导的小鼠 ALI 提供显著保护,同时改善巨噬细胞线粒体功能。C57BL/6 小鼠经口气管内滴注 LPS(1mg/kg)。LPS 吸入后 4 小时通过尾静脉给予 AdMSC-Exos。通过流式细胞术、H&E、定量实时 PCR、免疫荧光(IF)、共聚焦显微镜成像来研究肺组织炎症和巨噬细胞线粒体功能。并通过实验进一步观察外泌体的转移及其对 MH-S 细胞线粒体功能的影响。AdMSC-Exos 可以以剂量依赖的方式将干细胞衍生的线粒体成分转移到肺泡巨噬细胞中。AdMSC-Exos 可能通过补充受损的线粒体,表现出提高 mtDNA 水平、线粒体膜电位(MMP)、OXPHOS 活性和 ATP 生成的能力,同时缓解 LPS 刺激的巨噬细胞中 mROS 应激。通过 AdMSC-Exos 治疗恢复线粒体完整性使巨噬细胞向抗炎表型转变,表现为下调 IL-1β、TNF-α 和 iNOS 分泌,增加抗炎细胞因子 IL-10 和 Arg-1 的产生。当我们使用氯膦酸盐脂质体耗尽肺泡巨噬细胞时,AdMSC-Exos 的保护作用被大大削弱。AdMSC-Exos 可以有效地捐献线粒体成分,改善巨噬细胞线粒体完整性和氧化磷酸化水平,恢复气道巨噬细胞的代谢和免疫稳态,减轻肺炎症病理。